On the role and fate of LPS-dephosphorylating activity in the rat liver

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 2, 2006, Pages

  Tuin, Annemarie ^a,b   Huizinga Van Der Vlag, Ali ^a   Van Loenen Weemaes, Anne Miek M A ^a   Meijer, Dirk K F ^a   Poelstra, Klaas ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Alkaline phosphatase; Inflammation; Intestine; Lipopolysaccharide

Indexed keywords

ALKALINE PHOSPHATASE; ASIALOGLYCOPROTEIN RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; CD14 ANTIGEN; COLLAGEN TYPE 3; RNA;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CONTROLLED STUDY; ENZYME ACTIVITY; GLYCOGENOLYSIS; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL MEMBRANE; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; GLUCONEOGENESIS; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; KIDNEY; LIVER CELL; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE; WISTAR RAT;

ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, CD14; COLLAGEN TYPE III; ENTEROCYTES; GLUCONEOGENESIS; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; LIVER CIRRHOSIS; MALE; NITRIC OXIDE; PHOSPHORYLATION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33644856860     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00147.2005     Document Type: Article

References (50)

1. Aderem A and Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787, 2000.
2. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777, 2003.
3. Alpers DH, Zhang Y, and Ahnen DJ. Synthesis and parallel secretion of rat intestinal alkaline phosphatase and a surfactant-like particle protein. Am J Physiol Endocrinol Metab 268: E1205-E1214, 1995.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, and Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
5. Arias E, Anderson RN, Kung HC, Murphy SL, and Kochanek KD. Deaths: final data for 2001. Natl Vital Stat Rep 52: 1-115, 2003.
6. Bentala H, Verweij WR, Huizinga-Van der Vlag A, Loenen-Weemaes AM, Meijer DK, and Poelstra K. Removal of phosphate from lipid a as a strategy to detoxify lipopolysaccharide. Shock 18: 561-566, 2002.
7. Blom E, Ali MM, Mortensen B, and Huseby NE. Elimination of alkaline phosphatases from circulation by the galactose receptor. Different isoforms are cleared at various rates. Clin Chim Acta 270: 125-137, 1998.
8. Cormack DH. The digestive system. In: Essential Histology. Philadelphia, PA; Lippincott-Raven, 1993, p. 271-306.
9. Courdouhji MK, Guelfi JF, Fontanilles AM, Grozdea JD, and Vergnes HA. Characterization of alkaline phosphatase in polymorphonuclear neutrophils from normal sheep. Enzyme 40: 217-222, 1988.
10. Detmers PA, Zhou D, Powell D, Lichenstein H, Kelley M, and Pironkova R. Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase. J Immunol 155: 2085-2095, 1995.
11. Flegel WA, Baumstark MW, Weinstock C, Berg A, and Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 61: 5140-5146, 1993.
12. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, and Rapp JH. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 91: 1028-1034, 1993.
13. Harris HW, Rockey DC, and Chau P. Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology 27: 1341-1348, 1998.
14. Haziot A, Chen S, Ferrero E, Low MG, Silber R, and Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141: 547-552, 1988.
15. Henneke P and Golenbock DT. Innate immune recognition of lipopolysaccharide by endothelial cells. Crit Care Med 30: S207-S213, 2002.
16. Heumann D and Glauser MP. Pathogenesis of sepsis. Scientific American 1: 28-37, 1994.
17. Holst O, Thomas-Oates JE, and Brade H. Preparation and structural analysis of oligosaccharide monophosphates obtained from the lipopolysaccharide of recombinant strains of Salmonella minnesota and Escherichia coli expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur J Biochem 222: 183-194, 1994.
18. Hori Y, Takeyama Y, Ueda T, Nishikawa J, Yamamoto M, and Saitoh Y. Impaired transport of lipopolysaccharide across the hepatocytes in rats with cerulein-induced experimental pancreatitis. Pancreas 16: 148-153, 1998.
19. Hsu DZ, Chiang PJ, Chien SP, Huang BM, and Liu MY. Parenteral sesame oil attenuates oxidative stress after endotoxin intoxication in rats. Toxicology 196: 147-153, 2004.
20. Jia HP, Kline JN, Penisten A, Apicella MA, Gioannini TL, Weiss J, and McCray PB Jr. Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am J Physiol Lung Cell Mol Physiol 287: L428-L437, 2004.
21. Josza L, Lehto MU, Jarvinen M, Kvist M, Reffy A, and Kannus P. A comparative study of methods for demonstration and quantification of capillaries in skeletal muscle. Acta Histochem 94: 89-96, 1993.
22. Kaser A, Ludwiczek O, Waldenberger P, Jaschke W, Vogel W, and Tilg H. Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver 22: 380-387, 2002.
23. Koutelidakis I, Papaziogas B, Giamarellos-Bourboulis EJ, Makris J, Pavlidis T, Giamarellou H, and Papaziogas T. Systemic endotoxaemia following obstructive jaundice: the role of lactulose. J Surg Res 113: 243-247, 2003.
24. Koyama I, Matsunaga T, Harada T, Hokari S, and Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem 35: 455-461, 2002.
25. Marshall JC. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2: 391-405, 2003.
26. Meijer DK, Scholtens HB, and Hardonk MJ. The role of the liver in clearance of glycoproteins from the general circulation, with special reference to intestinal alkaline phosphatase. Pharm Weekbl Sci 4: 57-70, 1982.
27. Novikoff AB. Enzyme localizations with Wachstein-Meisel procedures: real or artifact. J Histochem Cytochem 15: 353-354, 1967.
28. Okada T, Zinchuk VS, and Seguchi H. Lipopolysaccharide administration increases acid and alkaline phosphatase reactivity in the cardiac muscle. Microsc Res Tech 58: 421-426, 2002.
29. Olinga P, Merema M, Hof IH, de Jong KP, Slooff MJ, Meijer DK, and Groothuis GM. Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab Dispos 26: 5-11, 1998.
30. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, and Kinoshita Y. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 170: 3977-3985, 2003.
31. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, and Brenner DA. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37: 1043-1055, 2003.
32. Peterson AA and McGroarty EJ. High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. J Bacteriol 162: 738-745, 1985.
33. Poelstra K, Bakker WW, Klok PA, Hardonk MJ, and Meijer DK. A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab Invest 76: 319-327, 1997.
34. Poelstra K, Bakker WW, Klok PA, Kamps JA, Hardonk MJ, and Meijer DK. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am J Pathol 151: 1163-1169, 1997.
35. Pugin J, Stern-Voeffray S, Daubeuf B, Matthay MA, Elson G, and Dunn-Siegrist I. Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 104: 4071-4079, 2004.
36. Reddi AH and Anderson WA. Collagenous bone matrix-induced endochondral ossification hemopoiesis. J Cell Biol 69: 557-572, 1976.
37. Reichling JJ and Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci 33: 1601-1614, 1988.
38. Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, and Berkel TJ. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 99: 2438-2445, 1997.
39. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova and F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225, 1994.
40. Ruiter DJ, van der MJ, Brouwer A, Hummel MJ, Mauw BJ, van der Ploeg JC, and Wisse E. Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 45: 38-45, 1981.
41. Sheen-Chen SM, Chau P, and Harris HW. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J Surg Res 80: 205-209, 1998.
42. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 189: 1777-1782, 1999.
43. 42a. Silverman MH and Ostro MJ. Bacterial Endotoxin in Human Disease: How Advances in Understanding the Role of Gram-Negative Bacteria and Endotoxin in Infectious Diseases and Complications May Improve the Development of Diagnostic and Treatment Options. Berkeley, CA: Xoma, 1998. [On-line: http://www.xoma.com: 8080/pdf/kpmgendo.pdf].
44. Sozinov AS. Systemic endotoxemia during chronic viral hepatitis. Bull Exp Biol Med 133: 153-155, 2002.
45. Su GL, Dorko K, Strom SC, Nussler AK, and Wang SC. CD14 expression and production by human hepatocytes. J Hepatol 31: 435-442, 1999.
46. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, Tompkins RG, and Martyn JA. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282: E386-E394, 2002.
47. Takayama K, Qureshi N, Raetz CR, Ribi E, Peterson J, Cantrell JL, Pearson FC, Wiggins J, and Johnson AG. Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities. Infect Immun 45: 350-355, 1984.
48. Tillyer CR, Rakhorst S, and Colley CM. Multicomponent analysis for alkaline phosphatase isoenzyme determination by multiple linear regression. Clin Chem 40: 803-810, 1994.
49. Treon SP, Thomas P, and Broitman SA. Lipopolysaccharide (LPS) processing by Kupffer cells releases a modified LPS with increased hepatocyte binding and decreased tumor necrosis factor-alpha stimulatory capacity. Proc Soc Exp Biol Med 202: 153-158, 1993.
50. Wiwanitkit V. High serum alkaline phosphatase levels, a study in 181 Thai adult hospitalized patients. [On-line: www.biomedcentral.com/content/pdf/1471- 2296-2-2.pdf] 2001.